Breast Reduction Mammoplasty
This clinical policy describes EmblemHealth's medical necessity criteria, documentation and coding guidance for reduction mammoplasty (breast reduction) and associated mastopexy when reconstructive, for members covered under EmblemHealth plans.
Added note that preparatory mastopexy or reduction mammaplasty prior to mastectomy may be medically necessary in certain women with macromastia and/or ptosis undergoing nipple-sparing mastectomy for genetic mutations or elevated cancer risk.
Intertriginous dermatitis criterion wording changed from 'Presence' to 'History' and photo language was modified previously.
Clarified that the minimum amount of breast tissue to be removed must be proportional to body surface area (BSA) per the Schnur scale.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.